EcoDrugPlus

Microtubule-Associated Protein Tau A

Ensembl ID : ENSDARG00000089314
Gene Symbol: MAPTA
5 Cross references
206 Possible Orthologues:

Microtubule-Associated Protein Tau B

Ensembl ID : ENSDARG00000087616
Gene Symbol: MAPTB
5 Cross references
161 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSDARG00000027552
Gene Symbol: MAPK1
101 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSDARG00000102730
Gene Symbol: MAPK10
31 Enzyme and pathways 5 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSDARG00000000857
Gene Symbol: MAPK14A
63 Enzyme and pathways 5 Cross references
167 Possible Orthologues:

Mitogen-Activated Protein Kinase 14b

Ensembl ID : ENSDARG00000028721
Gene Symbol: MAPK14B
63 Enzyme and pathways 5 Cross references
186 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSDARG00000070573
Gene Symbol: MAPK3
115 Enzyme and pathways 5 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 8a

Ensembl ID : ENSDARG00000031888
Gene Symbol: MAPK8A
51 Enzyme and pathways 5 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 8b

Ensembl ID : ENSDARG00000009870
Gene Symbol: MAPK8B
51 Enzyme and pathways 5 Cross references
223 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSDARG00000077364
Gene Symbol: MAPK9
31 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSDARG00000007825
Gene Symbol: MAP2K1
23 Enzyme and pathways 5 Cross references
215 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 2a

Ensembl ID : ENSDARG00000006609
Gene Symbol: MAP2K2A
23 Enzyme and pathways 5 Cross references
218 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).